Brief: Hookipa Announces FDA Clearance Of Ind Application For Hb-202/201 Clinical Trial To Treat Hpv-Positive Cancers
June 17 (Reuters) - HOOKIPA Pharma Inc HOOK.O :
* HOOKIPA ANNOUNCES FDA CLEARANCE OF ITS IND APPLICATION FOR
HB-202/201 CLINICAL TRIAL TO TREAT HPV-POSITIVE CANCERS
* HOOKIPA PHARMA - IN 2021, HOOKIPA EXPECTS TO ALSO COMBINE
HB-202/201 WITH AN APPROVED CHECKPOINT INHIBITOR
Source text for Eikon: ID:nGNXbmNb3p
Further company coverage: HOOK.O
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
Recent news on So-Young International
See all newsChina's So-Young International Q1 revenue rises on branded center expansion
Brief: So-Young International Q1 Revenue RMB 432.775 Million
China's So-Young Q4 revenue rises on branded center expansion
Medical aesthetics platform So-Young International's Q3 revenue up 4% on center expansion
So-Young International Inc reports results for the quarter ended June 30 - Earnings Summary